Analysis of Proteolytic and Fibrinolytic Activity of the Blood Plasma in Patients with Bronchial Asthma Combined with Obesity
Aim of the study — to conduct the analysis of the performance of proteolytic and fibrinolytic activity of the blood plasma in patients with bronchial asthma (BA) combined with obesity. Materials and methods. The study included 40 patients divided into groups. The basic group consisted of 20 patients with BA associated with obesity (ІI group), two comparison groups — of 10 patients with BA and normal body weight (I group) and 10 patients with obesity and without pathology of the bronchopulmonary system (ІІІ group). Control group included 10 apparently healthy persons. In patients with BA, there were investigated the indexes of proteolytic and fibrinolytic activity of the blood plasma. Results. Analysis of the obtained data in patients with BA showed an increase of activity of plasma coagulation factors: total fibrinolytic activity increased in comparison to the control group, and in patients with BA it was 1.46 ± 0.13 Е440/ml/h, while in apparently healthy persons — 1.23 ± 0.16 Е440/ml/h (р < 0.05). In addition, an increase was marked and in the group of patients with the isolated obesity (by 38.5 % as compared to the group of apparently healthy persons), that can be explained by the growth of activity of inflammatory process due to the immune changes related to biological activity of fatty tissue as an additional source of proinflammatory cytokines. Conclusions. In combination of bronchial asthma and obesity, there is an activation of fibrinolytic and proteolytic systems of the blood that leads to microcirculatory and hemostatic disorders, enhancement of inflammatory process. In obesity as the state of systemic inflammatory response, the activation of fibrinolytic and proteolytic blood systems is more significant, than in bronchial asthma.
Full Text:PDF (Українська)
Nakaz MOZ Ukrainy vid 19.03.2007 r. № 128 „Pro zatverdzhennia klinichnykh protokoliv nadannia medychnoi dopomohy za spetsialnistiu „pulmonolohiia”. [elektronnyi resurs]. – rezhym dostupu: www.ifp.kiev.ua. (Ukrainian)
Boulet LP, Boulay ME. Asthma-related comorbidities. Expert Rev. Respir. Med. 2011;5:377-393.
Ducharme FM, Krajinovic M. Steroid responsiveness and wheezing phenotypes. Paediatr. Respir. Rev. 2011;12:170-176.
Haldar P. Cluster analysis and clinical asthma phenotypes. Am. J. Respir. Crit. Care Med. 2008;1:218-224.
Kowalski ML. Clinical and immunological determinants of severe/ refractory asthma (SRA): association with Staphylococcal superantigen-specific IgE antibodies. Allergy. 2011;66(1):32-38.
Lessard A, Turcotte H, Cormier Y. Obesity and asthma: a specific phenotype? Chest. 2008;134:317-323.
Moore WC, Meyers DA, Wenzel SE. Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program. Am. J. Respir. Crit. Care Med. 2010;181:315-323.
Gershon A, Wang C, Guan J. Burden of comorbidity in individuals with asthma. Thorax. 2010;65(7):612-618.
This work is licensed under a Creative Commons Attribution 4.0 International License.
© "Publishing House "Zaslavsky", 1997-2019